#Digital PCR (dPCR) and Real-time PCR (qPCR) Market Trends

[factmrblog1]

Genetic Research Driving PCR Growth with Biotechnology Innovations

The global polymerase chain reaction (PCR) market is experiencing robust growth, with its valuation estimated at $6.2 billion in 2024 and projected to reach $16 billion by 2034, achieving a compound annual growth rate (CAGR) of 10%. PCR, a cornerstone of molecular diagnostics, has transformed healthcare by enabling rapid and accurate detection of diseases. Drawing from FactMR’s market analysis, this blog explores the drivers, challenges, innovations, and future prospects of the PCR market.

What is Polymerase Chain Reaction?

Polymerase chain reaction (PCR) is a laboratory technique used to amplify DNA segments, producing millions of copies from a single strand. This enables detailed analysis of genetic material, making PCR critical for diagnosing infectious diseases, genetic disorders, and cancers. Variants like real-time PCR (qPCR) and digital PCR (dPCR) enhance its precision and applicability in research, clinical diagnostics, and forensics.

PCR’s significance was underscored during the COVID-19 pandemic, where qPCR became the gold standard for detecting SARS-CoV-2 due to its high sensitivity and specificity. Its applications extend beyond diagnostics to include genetic research, forensic analysis, and biotechnology.

Key Market Drivers

The PCR market’s growth is driven by the increasing prevalence of infectious diseases and genetic disorders. Conditions like sexually transmitted infections, respiratory diseases, and hepatitis are boosting demand for PCR-based diagnostics. The technique’s ability to detect pathogenic DNA with high accuracy makes it indispensable in clinical settings.

Technological advancements are another key driver. Innovations like qPCR and dPCR have improved the speed, accuracy, and scalability of PCR tests. The development of portable, point-of-care PCR devices, such as Nuclein’s ‘Nuclein Anywhere’ test, has expanded access to diagnostics, particularly in home-based settings. FactMR notes that the rising adoption of these advanced systems is fueling market growth.

Government and private investments in healthcare and pharmaceutical R&D are also significant. Increased funding for developing rapid diagnostic kits, such as RT-qPCR for SARS-CoV-2 detection, is driving sales of PCR products. The expansion of healthcare infrastructure in developing economies further supports demand for clinical PCR solutions.

Regional Insights

North America, particularly the United States, dominates the PCR market, accounting for 45.6% of the North American market share by 2034. The region’s advanced healthcare infrastructure, high adoption of cutting-edge diagnostics, and significant R&D funding drive growth. The U.S. benefits from rising awareness of PCR products and their integration into clinical and research applications.

Japan is an emerging market in East Asia, driven by growing awareness among healthcare professionals of gene-based diagnostics. Public-private partnerships to develop novel PCR technologies are expected to accelerate growth in the region. Other regions, including Europe and Asia Pacific, are also seeing increased adoption due to expanding healthcare systems and research activities.

Challenges in the Market

The high cost of advanced PCR technologies, such as qPCR and dPCR, is a significant barrier. FactMR reports that qPCR devices range from $4,000 to $13,000 or more, while dPCR systems are even pricier. These costs limit adoption in developing economies, where budget constraints are common.

Another challenge is the complexity of PCR systems, which require skilled personnel and sophisticated infrastructure. This can hinder their use in resource-limited settings. Additionally, competition from alternative diagnostic methods, such as next-generation sequencing (NGS), may impact the PCR market in certain applications.

Innovations and Trends

Innovation is transforming the PCR market. Companies like SAGA Diagnostics are leveraging dPCR for non-invasive cancer detection, with products like ‘SAGAsafe’ enabling accurate diagnosis of multiple cancer types. Similarly, advancements in RT-qPCR kits have improved the detection of viral variants, maintaining their relevance post-COVID.

The development of portable and automated PCR systems is a key trend. Devices like Anitoa Systems’ MAx16 and Bio-Rad’s CFX Opus 96 Dx System offer rapid, user-friendly diagnostics, making PCR accessible in diverse settings. These innovations align with the growing demand for point-of-care and home-based testing.

Opportunities for Growth

The PCR market offers significant opportunities, particularly in developing economies where healthcare infrastructure is expanding. The rising prevalence of chronic and infectious diseases creates a steady demand for PCR diagnostics. Companies investing in affordable, portable PCR solutions can tap into these markets.

Collaborations between diagnostic companies and healthcare providers can also drive growth. By developing tailored PCR solutions for specific diseases, manufacturers can address unmet needs and expand their market presence. FactMR highlights that the increasing focus on early disease detection and genetic research will further boost demand.

Future Outlook

With a projected valuation of $16 billion by 2034, the PCR market is set for strong growth. Its critical role in diagnostics, coupled with ongoing innovations, ensures its relevance in healthcare and research. As global health challenges evolve, PCR will remain a cornerstone of molecular diagnostics, driving advancements in disease detection and treatment.

Conclusion

The PCR market’s rapid growth reflects its transformative impact on diagnostics and research. With a CAGR of 10% and a projected valuation of $16 billion by 2034, it offers immense potential for innovation and expansion. As technology advances and healthcare needs grow, PCR will continue to shape the future of medical diagnostics.

[healthcareindustryresearch]

Digital PCR and Real-Time PCR: Strategic Catalysts in the Future of Precision Diagnostics

In the evolving landscape of molecular diagnostics, two technologies have emerged as central pillars for innovation, accuracy, and business transformation: Digital PCR (dPCR) and Real-Time PCR (qPCR). These technologies are not merely analytical tools; they are strategic assets poised to redefine operational paradigms across biotechnology, pharmaceutical development, clinical diagnostics, and public health infrastructure. For senior executives and decision-makers, understanding the implications of dPCR and qPCR is essential to navigating the future of life sciences and diagnostics.

Request Sample Pages

The Strategic Differentiation: Digital PCR vs. Real-Time PCR

Real-Time PCR, long considered the industry standard, enables the quantification of nucleic acids during the exponential phase of the PCR process. It is widely valued for its speed, sensitivity, and throughput capabilities, making it a cornerstone in clinical diagnostics, pathogen detection, and gene expression analysis.

Digital PCR, a more recent advancement, provides absolute quantification without the need for reference standards or calibration curves. By partitioning a sample into thousands—or even millions—of discrete reactions, dPCR offers enhanced precision, sensitivity, and reproducibility, particularly valuable in detecting rare mutations, copy number variations, and low-abundance targets.

For business leaders, the distinction is not merely technical—it is strategic. qPCR remains indispensable for routine diagnostics and large-scale screening. Meanwhile, dPCR is carving a niche in high-value, high-complexity applications, enabling companies to offer differentiated, premium diagnostics and research solutions.

Real-World Applications Driving Enterprise Value

The implementation of PCR technologies is generating measurable impact across various sectors:

Clinical Diagnostics: qPCR continues to dominate in infectious disease detection due to its high-throughput capabilities. However, dPCR is emerging as the gold standard in oncology diagnostics, enabling ultra-sensitive detection of circulating tumor DNA (ctDNA) for early cancer screening and treatment monitoring.

Biopharmaceutical Manufacturing: Both qPCR and dPCR are integral in quality control and contamination detection. dPCR, with its high accuracy, is increasingly used to validate critical quality attributes (CQAs) of biologics, driving compliance and reducing batch failures.

Precision Medicine: dPCR facilitates individualized treatment strategies by enabling accurate quantification of genetic mutations and biomarkers. This aligns directly with value-based healthcare models that prioritize outcomes and cost-efficiency.

Agrigenomics and Food Safety: qPCR has become essential in ensuring GMO compliance and pathogen detection. The precision of dPCR is expanding its role in detecting adulterants and allergens with greater specificity.

These use cases reflect not only technical viability but also commercial scalability, with direct implications for operational efficiency, regulatory compliance, and product differentiation.

Emerging Trends and Market Dynamics

The molecular diagnostics market is entering a period of accelerated innovation, shaped by macro-level trends that senior decision-makers must watch closely:

Decentralization of Testing: With growing demand for point-of-care (POC) and near-patient diagnostics, there is a rising emphasis on miniaturized, integrated qPCR and dPCR platforms. This shift enables faster clinical decisions and enhances accessibility in remote or underserved regions.

Regulatory Evolution: Regulatory bodies are increasingly endorsing dPCR for its reliability and robustness, especially in applications like non-invasive prenatal testing (NIPT) and minimal residual disease (MRD) detection. Early alignment with these regulatory trends will be critical to future market access.

AI and Data Integration: As molecular diagnostics become more complex, integrating AI for data interpretation is transforming how results from qPCR and dPCR are analyzed and utilized. Automated workflows and intelligent analytics are enhancing diagnostic accuracy while reducing turnaround time.

Sustainability and Cost Pressures: Labs and manufacturers are seeking PCR systems that minimize reagent usage and energy consumption. Innovations in chip-based dPCR and ultra-fast qPCR are addressing both ecological and economic concerns.

These trends are not ephemeral—they signal a durable evolution in how molecular tools will be developed, deployed, and monetized.

Business Opportunities and Competitive Differentiation

Executives and strategists should consider several high-value opportunities emerging from the ongoing evolution of PCR technologies:

Platform Innovation and IP Strategy: Companies that invest in developing proprietary qPCR or dPCR platforms—or secure strategic patents—will gain defensible market positions. Modular platforms that integrate seamlessly into digital ecosystems offer high adaptability and lifecycle value.

Vertical Integration and Ecosystem Control: Controlling more of the value chain—from reagents to software—enables tighter quality control and recurring revenue opportunities. End-to-end PCR solutions are becoming a key driver of customer retention and profitability.

Expansion into Adjacent Markets: With dPCR enabling applications in environmental monitoring, water safety, and industrial microbiology, life science firms can diversify revenue streams beyond healthcare and pharma.

Strategic Collaborations: Aligning with academic institutions, healthcare providers, or data analytics firms can fast-track product development and market validation. These alliances can also help navigate regulatory pathways more efficiently.

Global Market Penetration: Emerging markets in Asia, Latin America, and Africa are rapidly investing in molecular diagnostics infrastructure. Offering scalable, cost-effective qPCR/dPCR solutions tailored to regional needs will be essential for global growth.

Each of these vectors represents not only revenue potential but also long-term strategic resilience.

Visionary Outlook: PCR in the Next Decade

Looking ahead, PCR technologies will not exist in isolation. They will function as part of a broader, interconnected diagnostic and therapeutic ecosystem:

Integration with Genomics and Proteomics: PCR platforms will increasingly be used alongside next-generation sequencing (NGS) and proteomic tools, delivering a multi-modal approach to disease detection and monitoring.

Personalized Health Monitoring: Wearable biosensors and at-home diagnostic kits may soon incorporate miniaturized PCR components, enabling continuous monitoring of biomarkers with clinical-grade accuracy.

Global Health Preparedness: As pandemics and emerging infectious diseases remain a persistent threat, governments and global health bodies will rely on both qPCR and dPCR for scalable, rapid response frameworks.

Precision Manufacturing: In biologics and gene therapy, dPCR will play a central role in ensuring batch-to-batch consistency, regulatory compliance, and product safety.

The trajectory is clear: PCR is not a static technology—it is an evolving platform with transformative implications across industries.

Strategic Imperatives for Decision-Makers

For C-suite executives and senior leaders, the path forward involves proactive engagement with the PCR technology curve:

Invest in Advanced Capabilities: Allocating capital to in-house PCR development or acquisition of innovative startups can yield long-term competitive advantages.

Build Cross-Functional Expertise: Collaborate across R&D, regulatory, and commercial teams to ensure alignment on PCR integration strategies.

Embrace Digital Transformation: Leverage data analytics, cloud platforms, and AI to maximize the value of PCR-generated data.

Monitor Policy and Reimbursement Trends: Early visibility into changing regulatory and payer landscapes will position companies to capitalize on emerging opportunities.

By taking a forward-thinking, enterprise-wide approach to PCR, organizations can not only stay competitive but lead in a diagnostics market that is rapidly moving from reactive to predictive.

Conclusion

Digital PCR and Real-Time PCR are far more than technical instruments—they are enablers of precision, platforms for innovation, and strategic levers for growth. As the global healthcare and life sciences sectors evolve toward greater personalization, automation, and resilience, PCR technologies will remain at the center of this transformation. The executives who recognize and act on this convergence today will define the industry leadership of tomorrow.

For more information, inquire now! Inquire Now

[skyquest-market-research]

Why Investors Are Eyeing the dPCR and qPCR Market for Growth Opportunities

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is experiencing robust growth as advancements in molecular diagnostics and biotechnology revolutionize the healthcare and research sectors. According to a comprehensive analysis by SkyQuest Technology, the market is projected to reach unprecedented heights, reflecting a compound annual growth rate (CAGR) of 8.1% during the forecast period. As these technologies gain prominence, industries worldwide are embracing their potential for precision diagnostics, disease monitoring, and scientific breakthroughs.

Market Size and Growth Projections

The global digital PCR (dPCR) and real-time PCR (qPCR) market is thriving due to the surge in demand for advanced diagnostic tools. With a market value estimated at USD 10.1 billion in 2023, it is anticipated to achieve a value of USD 20.36 billion by 2032. This substantial growth is attributed to the increasing prevalence of infectious diseases, rising cancer cases, and a growing focus on personalized medicine.

Request a Sample of the Report here: https://www.skyquestt.com/sample-request/digital-pcr-dpcr-and-real-time-pcr-qpcr-market

Key Market Drivers

The growth of the dPCR and qPCR market is influenced by several factors, including:

Rising Demand for Molecular Diagnostics With a greater emphasis on early detection and precision, the demand for molecular diagnostic tools is skyrocketing. dPCR and qPCR technologies enable highly sensitive and accurate analysis of genetic material, making them indispensable in diagnosing critical illnesses.

Advancements in Technology Continuous innovation in PCR technologies is leading to faster, more accurate, and cost-effective solutions, enhancing their adoption across various industries.

Applications in Research and Development The increasing focus on drug development and genetic research has further expanded the utility of dPCR and qPCR technologies in laboratories worldwide.

Market Segments

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is categorized based on technology, application, and end-user.

By Technology

Digital PCR (dPCR)

Real-Time PCR (qPCR)

By Application

Clinical Diagnostics

Research and Development

Forensic Applications

By End-User

Hospitals and Diagnostic Centers

Research Institutes

Biotech and Pharmaceutical Companies

Request a Customized Report Tailored to Your Needs: https://www.skyquestt.com/customization/digital-pcr-dpcr-and-real-time-pcr-qpcr-market

Regional Insights

The adoption of dPCR and qPCR technologies varies across regions, with distinct trends shaping the global market.

North America A dominant market due to advanced healthcare infrastructure, extensive research funding, and early adoption of innovative technologies.

Europe Strong emphasis on biotechnology and personalized medicine drives the market in countries like Germany, France, and the UK.

Asia-Pacific The fastest-growing region, fueled by the increasing prevalence of chronic diseases, expanding research activities, and government initiatives to enhance healthcare systems.

Latin America & Middle East Emerging markets show steady growth due to improving healthcare access and rising investments in diagnostic technologies.

Buy the Report to Get the Full Analysis: https://www.skyquestt.com/buy-now/digital-pcr-dpcr-and-real-time-pcr-qpcr-market

Top Players in the Market

The dPCR and qPCR market is highly competitive, with key players driving innovation and growth:

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

Roche Diagnostics

QIAGEN N.V.

Agilent Technologies

Merck KGaA

Takara Bio Inc.

Promega Corporation

Illumina, Inc.

Fluidigm Corporation

View full ToC and List of Companies here: https://www.skyquestt.com/report/digital-pcr-dpcr-and-real-time-pcr-qpcr-market

Emerging Trends in the dPCR and qPCR Market

Increased Focus on Point-of-Care Diagnostics Portable and user-friendly devices are making molecular diagnostics accessible even in resource-limited settings.

Integration of AI and Big Data Advanced analytics are enhancing the accuracy and efficiency of PCR technologies, paving the way for groundbreaking discoveries.

Growth in Personalized Medicine With a shift towards tailored treatments, dPCR and qPCR technologies are playing a pivotal role in identifying genetic markers and designing customized therapies.

Expansion of Applications Beyond Healthcare The utility of these technologies is extending into food safety, agriculture, and environmental monitoring, further diversifying market opportunities.

Conclusion

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is set to transform diagnostics and research on a global scale. As technological innovations continue to enhance the precision and accessibility of these tools, the market offers promising opportunities for growth across diverse sectors. Companies focusing on innovation, adaptability, and application expansion are poised to lead in this rapidly evolving industry.

[heathcareforallworld]

Trends and Projections for the Taq DNA Polymerase Market

The Taq DNA Polymerase Market is witnessing significant growth due to the increasing demand for polymerase chain reaction (PCR) technologies in various fields such as medical diagnostics, biotechnology, and forensic science. As the backbone of PCR, Taq DNA polymerase is indispensable for amplifying DNA sequences, making it a crucial component in research and clinical laboratories worldwide. This article delves into the market size, share, industry trends, and forecasts for the Taq DNA polymerase market through 2032.

Market Overview

Taq DNA polymerase is a thermostable enzyme extracted from the bacterium Thermus aquaticus, which is capable of withstanding high temperatures required for PCR. This enzyme's ability to replicate DNA sequences efficiently and accurately under thermal cycling conditions has revolutionized molecular biology and genetic research.

Market Size and Share

Taq dna polymerase Market Size was estimated at 1.6 (USD Billion) in 2023. The Taq Dna Polymerase Market Industry is expected to grow from 1.69(USD Billion) in 2024 to 2.53 (USD Billion) by 2032. The taq dna polymerase Market CAGR (growth rate) is expected to be around 5.19% during the forecast period (2024 - 2032).

North America currently holds the largest market share, accounting for over 40% of the global market. This dominance is attributed to the region's well-established biotechnology and pharmaceutical industries, extensive research activities, and the presence of key market players. Europe follows closely, with significant contributions from countries like Germany, the UK, and France. The Asia-Pacific region is expected to witness the fastest growth, driven by increasing investments in biotechnology, rising healthcare expenditure, and growing awareness about molecular diagnostics.

Industry Trends

Technological Advancements: The Taq DNA polymerase market is benefiting from continuous technological innovations. The development of high-fidelity and fast-cycling Taq polymerases has enhanced the efficiency and accuracy of PCR, expanding its applications in various fields.

Rising Demand for Molecular Diagnostics: The increasing prevalence of infectious diseases, genetic disorders, and cancer has fueled the demand for molecular diagnostics. Taq DNA polymerase plays a crucial role in diagnostic assays, including COVID-19 testing, driving market growth.

Expansion of Personalized Medicine: The shift towards personalized medicine, which relies on genetic profiling for tailored treatments, is boosting the demand for Taq DNA polymerase. PCR-based techniques are integral to genetic testing and the development of personalized therapies.

Growing Research and Development Activities: The surge in research and development activities in genomics, proteomics, and biotechnology is propelling the demand for Taq DNA polymerase. Government and private sector investments in research are further stimulating market growth.

Increased Forensic Applications: The application of PCR in forensic science for DNA profiling and criminal investigations is expanding. Taq DNA polymerase is a vital tool in forensic labs, aiding in the accurate identification of individuals from biological samples.

Market Drivers

Advancements in PCR Technology: Innovations such as real-time PCR (qPCR) and digital PCR (dPCR) are driving the adoption of Taq DNA polymerase. These advanced techniques offer higher sensitivity, specificity, and quantification capabilities, broadening the scope of PCR applications.

Growing Biotechnology Industry: The biotechnology industry's rapid growth, coupled with increasing investments in genetic research, is boosting the demand for Taq DNA polymerase. The enzyme is essential for various applications, including cloning, sequencing, and gene expression analysis.

Increasing Prevalence of Genetic Disorders: The rising incidence of genetic disorders and the need for early diagnosis and treatment are driving the demand for PCR-based diagnostic tests. Taq DNA polymerase is a key component in these tests, contributing to market growth.

COVID-19 Pandemic: The COVID-19 pandemic has significantly increased the demand for PCR testing, highlighting the importance of Taq DNA polymerase. The enzyme's critical role in detecting the virus has led to a surge in production and sales.

Challenges

High Cost of Enzyme Production: The production of high-quality Taq DNA polymerase involves complex processes and significant investment, leading to high costs. This can be a barrier for small-scale laboratories and research institutions.

Competition from Alternative Enzymes: The market faces competition from alternative DNA polymerases with improved properties, such as higher fidelity and faster cycling times. The development and adoption of these alternatives can impact the market share of Taq DNA polymerase.

Stringent Regulatory Requirements: The stringent regulatory requirements for the approval and commercialization of diagnostic and research products can pose challenges for market players. Compliance with these regulations can be time-consuming and costly.

Market Forecast (2024-2032)

The Taq DNA polymerase market is poised for substantial growth over the forecast period. Key factors contributing to this growth include:

Expanding Applications in Diagnostics and Research: The ongoing advancements in PCR technology and the expanding applications in diagnostics and research are expected to drive market growth. The enzyme's versatility and reliability make it indispensable in various fields.

Increasing Investments in Biotechnology: The increasing investments in biotechnology and genetic research by governments, private companies, and research institutions will propel the demand for Taq DNA polymerase. The enzyme's role in groundbreaking research and development activities will continue to drive market expansion.

Emerging Markets in Asia-Pacific: The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare expenditure, increasing biotechnology investments, and growing awareness about molecular diagnostics. Countries like China, India, and Japan are key markets to watch.

Adoption of Personalized Medicine: The shift towards personalized medicine and the growing demand for genetic testing will boost the market for Taq DNA polymerase. The enzyme's critical role in genetic analysis and the development of personalized therapies will drive its adoption.

Conclusion

The Taq DNA polymerase market is on a robust growth trajectory, driven by technological advancements, increasing demand for molecular diagnostics, and expanding research and development activities. Key players in the industry are focusing on product development, strategic collaborations, and expanding their geographical presence to capitalize on the growing demand for Taq DNA polymerase.

[delvenservices]

PCR Technologies Market Analysis by Application, Technology, End User & Geography

PCR Technologies Market by Technology (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene expression, diagnostics), End user (Academia, pharma-biotech, applied) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa and South America)

Market Overview

The global PCR technologies market is projected to reach USD 9.8 billion by 2025 from USD 7.8 billion in 2021, at a CAGR of 6.3% from 2020 to 2028.

Continuous technological advancements in PCR technologies, Target diseases and genetic disorders; the development of miniaturized portable instruments, and incorporation of robotics; increasing investments, funds, and grants for research activities; increasing use of biomarker profiling for disease diagnostics; and the successful completion of the Human Genome Project are some of the factors that have supported long-term expansion for PCR Technologies Market.

To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/pcr-technologies-market-trends-forecast-till-2028

Key Findings

PCR Technologies Market is segmented into technique, product type, application, end-user, and geography.

The technique segment is segmented into conventional PCR, real-time PCR, digital PCR, reverse transcription PCR, hot-start PCR, and multiplex PCR.

The product type segment is segmented into instruments, reagents & consumables, and software & services.

The application segment is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid detection, nucleic acid synthesis, standard validation/verification, diagnostic applications, and environmental applications.

Geographically, PCR Technologies Market is sub-segmented into North America, Europe, Asia-Pacific, Middle East, and Africa, and South America and insights are provided for each region and major countries within the regions

Make an Inquiry Before Buying: https://www.delvens.com/Inquire-before-buying/pcr-technologies-market-trends-forecast-till-2028

Competitive Landscape

Key players in PCR Technologies Market are

Thermo Fisher Scientific, Inc. (US),

F. Hoffman-La Roche Ltd. (Switzerland),

Bio-Rad Laboratories, Inc. (US),

QIAGEN N.V. (Germany),

Takara Bio, Inc. (Japan),

Agilent Technologies, Inc. (the US),

bioMérieux S.A. (France),

Fluidigm Corporation (US),

Danaher Corporation (US),

Abbott Laboratories (US),

Merck KGaA (Germany),

Becton Dickinson and Company (US),

Promega Corporation (US),

Eppendorf AG (Germany),

Analytik Jena AG (Germany).

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors

Gain authentic and granular data access for PCR Technologies market to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Get the Direct Order for the Report: https://www.delvens.com/checkout/pcr-technologies-market-trends-forecast-till-2028

The PCR Technologies Market report answers a number of crucial questions, including:

Which companies dominate the PCR Technologies Market?

What current trends will influence the market over the next few years?

 What are the market's opportunities, obstacles, and driving forces?

What predictions for the future can help with strategic decision-making?

What advantages does market research offer businesses?

Which particular market segments should industry players focus on in order to take advantage of the most recent technical advancements?

What is the anticipated growth rate for the market economy globally?

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

Read More from Delvens:

[hustler0101]

This report studies the Real-time PCR (qPCR) and Digital PCR (dPCR) market size (value and volume) by players, regions, product types and end industries, history data 2018-2022 and forecast data 2023-2030; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

[marketresearchnews1242]

Global Digital PCR Market Competitions From Opponents Research 2022

The healthcare vertical is witnessing an ever-increasing need for automation, thereby leading to quick service provision for bridging existential gap between medical professionals and users. One of the most profit-making healthcare technologies is Artificial Intelligence, which enables automated service provision. The application areas include collection, management, and processing a huge quantity of user data. This would be the behaviour of the Digital PCR Market in the forecast period. Digital PCR Market Share, Growth, Trends And Forecast To 2031| value of US$ 347 Mn at a CAGR of 9.3%

The global digital PCR market is worth more than US$ 132 Mn at present. Demand for digital PCR is estimated to surge at a CAGR of 9.3% with an estimated value of US$ 347 Mn by 2031. User-friendly instruments of digital PCR, novel applications of digital PCR, and automation in advanced digital PCR instruments are some of the key trends in the market.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/20476

Digital PCR, or dPCR, is a new quantitative PCR method that enables ultrasensitive and reproducible detection as well as quantification of nucleic acid. It is an alternative method to conventional real-time qPCR, where the amplification reaction remains same but the method of quantifying the target sample differs.

Rising awareness about advanced molecular diagnostics is set to enhance the utilization of dPCR. Molecular diagnostics, specifically nucleic acid-based techniques for the detection of infectious diseases are rapidly growing approaches in clinical diagnostic laboratories. These techniques have been evolving since their development, including advances in digital PCR technologies that can now aid in the precise diagnosis of life-threatening diseases such as cancer and Ebola. There are several digital PCR-based diagnostic kits and assays for multiple diseases that have been introduced in molecular diagnosis over the previous decade.

Increasing global funding in research & development is adjacent to driving the demand of digital PCRs. Application of PCR-based techniques in drug discovery, genomics, and personalized medicine has augmented its penetration to reach the field of point-of-care molecular diagnostics. To address the global disease burden, there is a recent surge in the expenditure that contributes to the research and development of disease-related scientific studies. The trend is also encouraging molecular diagnostic manufacturers to invest more and support ongoing research in government and non-profit organizations.

Additionally, the National Institute of Health (NIH) has started the precision medicine initiative to address the issues and time associated with disease diagnosis and treatment. As opposed to the ‘one-size-fits-all’ treatment approach, precision medicine is an innovative approach that considers variety in people’s genes, environments, and lifestyles. Implementation of precision medicine has led to new discoveries and several FDA approvals for treatments pertaining to specific characteristics of an individual.

Company Profiles:

Bio-Rad Laboratories, Inc.

Agilent Technologies

Thermo Fisher Scientific Inc.

Fluidigm Corp

Formulatrix, Inc

JN Medsys

ADJUST

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/20476

Key Takeaways from Market Study

By product, instruments are expected to hold over 70% market value share by the end of 2031, primarily because of the presence of key market players for production worldwide.

Based on application, basic research is leading with nearly 35% market share, owing to extensive research opportunities in infection diagnosis and drug discovery.

Research institutes dominated the end-user segment with a share of around 69.4% in 2020, due to increasing number of molecular biology companies focusing on infection diagnostics after the COVID-19 pandemic.

By region, North America is slated to be the largest market with a value share of 35% by the end of the forecast period (2021 to 2031).

“Advancements in technology and application of digital PCR in drug discovery are anticipated to propel demand for as a measure for disease detection and prevention,” says an analyst of Persistence Market Research.

Market Competition

Acquisitions, mergers, expansions, and product launches are the key strategies adopted by manufacturers to increase their consumer base across geographies.

On October 28, 2021, Bio-Rad Laboratories projected a growth rise in Q3 revenue after acquisition of dPCR maker, Dropworks.

On September 20, 2021, Thermofisher launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.

On January 14, 2019, Qiagen NV agreed to acquire certain molecular testing assets from Formulatrix Inc., including the CONSTELLATION® series of instruments.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the digital PCR market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on the product (instruments, consumables, and service), application (clinical diagnostics, basic research, applied research, and forensic testing), and end user (pharmaceutical companies, research institutes, forensic labs and agriculture companies), across seven key regions of the world.

Key geographies evaluated in this report are: North America – U.S, Canada Europe – France, Germany, Italy, Spain, and the UK, Eastern Europe, CIS APAC – China, India, Japan, Australia, Others Latin America – Argentina, Brazil, Others

Access Full Report@ https://www.persistencemarketresearch.com/checkout/20476

Key Questions Answered in This Report.

What will the Market growth rate in Future?

What are the key factors driving the global Market?

Who are the key manufacturers in Market space?

What are the opportunities and threats faced by the vendors in the global industry?

What are sales, revenue, and price analysis by regions of industry?

About Us: Persistence Market Research

Contact Us:

Persistence Market Research           Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 Sales ��� sales@persistencemarketresearch.com

[balrajgis]

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Demand, Overview, Size, Trend | Thermo Fisher Scientific, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd.

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market report from Global Insight Services is the single authoritative source of intelligence on Digital PCR (dPCR) and Real-time PCR (qPCR) Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Polymerase chain reaction (PCR) is a method used to amplify a specific region of DNA. The DNA is first denatured into single strands, and then primers have added that bind to the target region. The DNA is then amplified using a thermostable DNA polymerase. PCR can be used to amplify a specific region of DNA, or it can be used to generate large quantities of a specific DNA sequence.

Get Free Sample Copy of This Report – https://www.globalinsightservices.com/request-sample/GIS20471/

Key Trends

Digital PCR (dPCR) and Real-time PCR (qPCR) technology are two of the most popular methods for PCR. dPCR is a newer technology that is becoming increasingly popular due to its higher accuracy and precision. qPCR is still the most widely used method due to its ease of use and lower cost.

Some of the key trends in dPCR and qPCR technology include:

– Increased accuracy and precision: dPCR is more accurate and precise than qPCR, making it the preferred method for many applications.

Key Drivers

Digital PCR (dPCR) and Real-time PCR (qPCR) are two of the most popular methods for PCR-based detection of nucleic acids. Both methods are highly sensitive and specific, and can be used for a variety of applications including gene expression analysis, pathogen detection, and genotyping. dPCR is typically more sensitive than qPCR, due to the fact that dPCR can quantify absolute copy numbers of target sequences, while qPCR can only relative copy numbers. In addition, dPCR is not affected by PCR inhibitors, while qPCR can be.

Market Segmentation 

By Technology 

Quantitative

Digital

By Product 

Consumables & Reagents

Instruments

By Application 

Clinical

Research

By Region:

North AmericaThe U.S.

Get A Customized Scope to Match Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS20471

Key Players

Thermo Fisher Scientific

Bio-Rad Laboratories Inc.

F. Hoffmann-La Roche, Ltd.

Abbott Laboratories

Agilent Technologies

Analytik Jena AG

Becton Dickson and Company

BioMerieux SA

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Excel data pack included with all report purchases

Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[sandlerresearch]

Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospitals & Diagnostic Centers, Pharma Biotech, CROs) - Global Forecast to 2025 published on

https://www.sandlerresearch.org/digital-pcr-dpcr-and-real-time-pcr-qpcr-market-by-product-instruments-reagents-consumables-software-services-application-clinical-research-forensic-end-user-hospitals-diagnostic-c.html

Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospitals & Diagnostic Centers, Pharma Biotech, CROs) - Global Forecast to 2025

“The dPCR and qPCR market is projected to grow at a CAGR of 9.0% during the forecast period (2020–2025).”

The global dPCR and qPCR market size is projected to reach USD 7.6 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 9.0%. The growth of this market is driven majorly by factors such as the rising incidence of target infectious diseases and genetic disorders; technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project. On the other hand, high instrument costs—especially that of dPCR—and the technical limitations of PCR are restraining market growth.

“By application, the clinical applications segment (of qPCR) is expected to grow at the highest CAGR during the forecast period.”

Based on application, the qPCR market is segmented into clinical applications, research applications, and forensic applications. The clinical applications segment is expected to register the highest growth during the forecast period. The key factors driving the market growth include the growing usage of qPCR in disease diagnosis, rising incidence of infectious & genetic diseases, and growing public emphasis on early & effective disease diagnosis & treatment..

“By end-user, the hospitals and diagnostics centers segment dominated the dPCR market in 2019.”

Based on end-user, the dPCR market is segmented into Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories. The Hospitals and Diagnostic Centers segment accounted for the largest share of the dPCR market in 2019, primarily due to the growing demand for early and efficient disease diagnosis and treatment, increasing number of dPCR product launches for diagnostic applications, benefits offered by dPCR in disease diagnosis (as compared to other PCR technologies), and growing public awareness related to the benefits offered by dPCR in disease diagnosis.

“Asia Pacific dPCR and qPCR market is expected to witness the highest growth during the forecast period.”

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the ongoing expansion & modernization of the healthcare infrastructure in emerging Asian countries; increasing number of research projects in China, India, and Japan in the field of genomics and cancer; the rising trend of clinical research being outsourced to Asia-based CROs by leading drug manufacturing companies; and continuous government support for genomics-based research activities in emerging Asia Pacific countries.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3–21%

By Designation: D-level–14%, C-level–10%, and Others–78%

By Region: North America–31%, Europe–33%, Asia Pacific–19%, RoW-18%

Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland) are the key players operating in this market. Other prominent players are Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Switzerland), Becton Dikinson and Company (US), bioMérieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA  (Germany), QIAGEN N.V.  (Netherlands), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), and Quidel Corporation (US).

Research Coverage:

The report analyzes the dPCR and qPCR market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a more significant share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the dPCR and qPCR market

Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the dPCR and qPCR market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global dPCR and qPCR market

Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of leading players in the dPCR and qPCR market

[wiseguy05]

Global Metal Credit Cards Market By Type, By Application, By Segmentation, By Region, and By Country 2020-2026

Metal credit cards are credit cards made from metal materials. It is heavier than the common plastic metal card, the production process is more complicated, and generally has more added value. Metal credit cards are often tailored to the customer.

Also Read: https://www.openpr.com/news/2094042/covid-19-impact-on-global-metal-credit-cards-market-dynamics

 Metal credit cards aren’t just for the wealthy with sky-high annual fees. Now three no-annual-fee credit cards carry some heft when plunked down on a restaurant table. Currently, there are many players in this market. Composecure, CPI Card Group, Gemalto, X-Core, G&D and some others are playing important roles in Metal Credit Cards industry. The market is relatively concentrated for now and is seeing to be more concentrated.In market, revenue of Metal Credit Cards in North America will increase to be 1402 M USD in 2025 from 248 M USD in 2018, which is the biggest consumption area in current market pattern. Europe ranks the second largest consumption area, with revenue of 173 USD in 2018. There are many different types of Metal Credit Cards. The market can be segmented into: Hybrid Metal Card, Veneer Metal Card, Full Metal Card and Others. Hybrid Metal Card Type is the most commonly used and efficient types and took 62.27% market share in 2018. By application, Standard Cards is the largest consumer group, with market share of 86.69% in 2018. The global Metal Credit Cards market is valued at 510 million US$ in 2018 and will reach 2918.6 million US$ by the end of 2025, growing at a CAGR of 24.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Metal Credit Cards market based on company, product type, end user and key regions.

Also Read: https://www.openpr.com/news/969652/Rice-Wine-Global-Market-Key-Players-SAVEUR-Kuaijishan-Jinfeng-Wine-PAGOOA-Nuerhong-Analysis-and-Forecast-to-2025.html

 This report studies the global market size of Metal Credit Cards in key regions like North America, Europe, China and South America, focuses on the consumption of Metal Credit Cards in these regions. This research report categorizes the global Metal Credit Cards market by top players/brands, region, type and end user. This report also studies the global Metal Credit Cards market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

Also Read: http://www.marketwatch.com/story/specialty-chemicals-market-2021-industry-size-share-price-trend-and-forecast-to-2026-2021-01-21

 The following manufacturers are covered in this report, with sales, revenue, market share for each company: Composecure CPI Card Group Gemalto X-Core G&D Goldpac Valid ...

Metal Credit Cards market size by Type Full Metal Card Hybrid Metal Card Veneer Metal Card Others

Also Read: http://www.marketwatch.com/story/digital-pcr-dpcr-and-real-time-pcr-qpcr-2021-market-estimation-dynamics-outlook-research-trends-and-forecasts-to-2025-2021-01-22

 In 2018, Hybrid Metal Card accounted for a major share of 64% in the global Metal Credit Cards market. And this product segment is poised to reach 1842 M USD by 2025 from 498 M USD in 2019.

Metal Credit Cards market size by Applications Standard Cards Custom Cards

In Metal Credit Cards market, Standard Cards segment holds an important share in terms of application, and it is expected to reach a volume of 26166 (K Units) by 2025, at a CAGR of 26.4% during 2018 and 2025. It means that Metal Credit Cards will be promising in the Standard Cards field in the next couple of years.

Market size by Region North America United States Canada Mexico Europe Germany France UK Italy Russia Asia-Pacific China Japan South Korea India Australia Indonesia Thailand Malaysia Philippines Vietnam Central & South America Brazil Middle East & Africa Turkey GCC Countries Egypt South Africa

The study objectives of this report are: To study and analyze the global Metal Credit Cards market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Metal Credit Cards market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Metal Credit Cards companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Metal Credit Cards submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Metal Credit Cards are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025

ALSO READ: http://www.marketwatch.com/story/hot-water-storage-tank-industry-production-and-demand-competition-news-and-trends-forecasts-to-2025-2021-01-20

 About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

 Contact Us:

NORAH TRENT                                                      

sales@wiseguyreports.com       

Ph: +162-825-80070 (US)                          

Ph: +44 2035002763 (UK)  

[marketresearchnewsdbmr]

QPCR and dPCR Market by Types, Risk Factor, Drivers, Market Size, Demand, Opportunities, Shares | Enzo Life Sciences, Inc.,; Fluidigm Corporation; Danaher; Abbott; Merck KGaA

QPCR and dPCR Market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global QPCR and dPCR market.Few of the major competitors currently working in the qPCR and dPCR market are Thermo Fisher Scientific; F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; QIAGEN; Takara Bio Inc.; Agilent Technologies, Inc.; bioMérieux SA; Fluidigm Corporation; Danaher; Abbott; Merck KGaA; Promega Corporation; BD; Meridian Bioscience, Inc.; Analytik Jena AG; Eppendorf AG; BIONEER COPORATION; Enzo Life Sciences, Inc.,; Quantabio; Formulatrix; JN Medsys; Thomas Scientific and Biomeme, Inc.

Global qPCR and dPCR Market is expected to rise from its initial estimated value of USD 3.64 billion in 2018 to a projected value of USD 7.14 billion by 2026, registering a CAGR of 8.78% in the forecast period of 2019-2026.

Get Exclusive Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-qpcr-and-dpcr-market

qPCR (Quantitative Polymerase Chain Reaction), also known as Real-Time Polymerase Chain Reaction can be defined as a diagnostic technique/method. This method involves the monitoring of DNA molecule in real-time rather than at the concluding stage in conventional PCR techniques.

dPCR (Digital Polymerase Chain Reaction) is a quantitative method of measuring the presence/amount of DNA and RNA present in a particular sample. Though, the results of this method are more precise and correct, lack of knowledge regarding the method can prove to be a factor that results in incorrect results.

Market Drivers: Global qPCR and dPCR Market

Increasing adoption of qPCR and qPCR in diagnostics which has been a result of rising prevalence of infectious and genetic diseases

Innovations & advancements related to technology and increased investments in the market from private & public sectors; these factors are expected to drive the market growth

Market Restraints:

Factors such as high costs, lack of knowledge and skills for professionals are one of the major factors that act as a restraint to the market growth

Global QPCR and dPCR Market Size, Status and Forecast 2019 – 2020

1 Market Overview

2 Manufacturers Profiles

3 Global QPCR and dPCR Sales, Revenue, Market Share and Competition by Manufacturer

4 Global QPCR and dPCR Market Analysis by Regions

5 North America QPCR and dPCR by Countries

6 Europe QPCR and dPCR by Countries

7 Asia-Pacific QPCR and dPCR by Countries

8 South America QPCR and dPCR by Countries

9 Middle East and Africa QPCR and dPCR by Countries

10 Global QPCR and dPCR Market Segment by Type

11 Global QPCR and dPCR Market Segment by Application

12 QPCR and dPCR Market Forecast

13 Sales Channel, Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendixes

Access Detailed TOC@ https://www.databridgemarketresearch.com/toc/?dbmr=global-qpcr-and-dpcr-market

The Report Highlights

Historic and forecasted QPCR and dPCR market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares.

Highlights and compares key application/product categories for growth trends and revenue forecast.

QPCR and dPCR Market size, revenue and unit sales according to each region

Cross category comparison – Growth and revenue comparison for product categories, historic and forecast through 2026.

QPCR and dPCR Market share of top key players

Current trends and recent Developments

Scope of the QPCR and dPCR Market Report

QPCR and dPCR Market (Actual Period: 2017-2018, Forecast Period: 2019-2020)

QPCR and dPCR Market – Size, Growth, Forecast

Analysis by Type:

Regional Analysis – Actual Period: 2017-2018, Forecast Period: 2019-2020

QPCR and dPCR Market – Size, Growth, Forecast

QPCR and dPCR Market Analysis by Type

Access Full Reports @ https://www.databridgemarketresearch.com/reports/global-qpcr-and-dpcr-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[freesuitwhispers]

Global  Digital PCR (dPCR) and Real-Time PCR (qPCR)  Market Analysis, Trends and Insights 2020-2026

Summary - A new market study, titled “Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2020 by Company, Regions, Type and Application, Forecast to 2025” has been featured on WiseGuyReports.

Market Overview

The global Digital PCR (dPCR) and Real-Time PCR (qPCR) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1562.5 million by 2025, from USD 1214.2 million in 2019.

 The Digital PCR (dPCR) and Real-Time PCR (qPCR) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Also Read: https://marketersmedia.com/digital-pcr-dpcr-and-real-time-pcr-qpcr-global-market-trends-future-scope-top-key-players-and-forecast-to-2026/88961948

Market segmentation

Digital PCR (dPCR) and Real-Time PCR (qPCR) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

 By Type, Digital PCR (dPCR) and Real-Time PCR (qPCR) market has been segmented into:

dPCR

qPCR

 By Application, Digital PCR (dPCR) and Real-Time PCR (qPCR) has been segmented into:

Clinical

Research

Forensic

 Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Digital PCR (dPCR) and Real-Time PCR (qPCR) market presented in the report. This section sheds light on the sales growth of different regional and country-level Digital PCR (dPCR) and Real-Time PCR (qPCR) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Digital PCR (dPCR) and Real-Time PCR (qPCR) market.

 The report offers in-depth assessment of the growth and other aspects of the Digital PCR (dPCR) and Real-Time PCR (qPCR) market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

 Competitive Landscape and Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Share Analysis

Digital PCR (dPCR) and Real-Time PCR (qPCR) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Digital PCR (dPCR) and Real-Time PCR (qPCR) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Digital PCR (dPCR) and Real-Time PCR (qPCR) sales, revenue and market share for each player covered in this report.

 The major players covered in Digital PCR (dPCR) and Real-Time PCR (qPCR) are:

Thermo Fisher Scientific

Abbott

Qiagen

Roche

Danaher

Bio-Rad

Becton Dickinson

Agilent

Takara

Merck

FOR MORE DETAILS: https://www.wiseguyreports.com/reports/4932697-global-digital-pcr-dpcr-and-real-time-pcr

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.                

 Contact Us:

NORAH TRENT                                                    

sales@wiseguyreports.com      

Ph: +162-825-80070 (US)                          

Ph: +44 203 500 2763 (UK)      

[marketresearchnews1242]

Digital Pcr Industry Report 2022 by Major Manufacturers Introduction and Market Data

Digital PCR Market 2022

The healthcare vertical is witnessing an ever-increasing need for automation, thereby leading to quick service provision for bridging existential gap between medical professionals and users. One of the most profit-making healthcare technologies is Artificial Intelligence, which enables automated service provision. The application areas include collection, management, and processing a huge quantity of user data. This would be the behaviour of the Digital PCR Market in the forecast period. Digital PCR Market Share, Growth, Trends And Forecast To 2031| value of US$ 347 Mn at a CAGR of 9.3%

The global digital PCR market is worth more than US$ 132 Mn at present. Demand for digital PCR is estimated to surge at a CAGR of 9.3% with an estimated value of US$ 347 Mn by 2031. User-friendly instruments of digital PCR, novel applications of digital PCR, and automation in advanced digital PCR instruments are some of the key trends in the market.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/20476

Digital PCR, or dPCR, is a new quantitative PCR method that enables ultrasensitive and reproducible detection as well as quantification of nucleic acid. It is an alternative method to conventional real-time qPCR, where the amplification reaction remains same but the method of quantifying the target sample differs.

Rising awareness about advanced molecular diagnostics is set to enhance the utilization of dPCR. Molecular diagnostics, specifically nucleic acid-based techniques for the detection of infectious diseases are rapidly growing approaches in clinical diagnostic laboratories. These techniques have been evolving since their development, including advances in digital PCR technologies that can now aid in the precise diagnosis of life-threatening diseases such as cancer and Ebola. There are several digital PCR-based diagnostic kits and assays for multiple diseases that have been introduced in molecular diagnosis over the previous decade.

Increasing global funding in research & development is adjacent to driving the demand of digital PCRs. Application of PCR-based techniques in drug discovery, genomics, and personalized medicine has augmented its penetration to reach the field of point-of-care molecular diagnostics. To address the global disease burden, there is a recent surge in the expenditure that contributes to the research and development of disease-related scientific studies. The trend is also encouraging molecular diagnostic manufacturers to invest more and support ongoing research in government and non-profit organizations.

Additionally, the National Institute of Health (NIH) has started the precision medicine initiative to address the issues and time associated with disease diagnosis and treatment. As opposed to the ‘one-size-fits-all’ treatment approach, precision medicine is an innovative approach that considers variety in people’s genes, environments, and lifestyles. Implementation of precision medicine has led to new discoveries and several FDA approvals for treatments pertaining to specific characteristics of an individual.

Company Profiles:

Bio-Rad Laboratories, Inc.

Agilent Technologies

Thermo Fisher Scientific Inc.

Fluidigm Corp

Formulatrix, Inc

JN Medsys

ADJUST

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/20476

Key Takeaways from Market Study

By product, instruments are expected to hold over 70% market value share by the end of 2031, primarily because of the presence of key market players for production worldwide.

Based on application, basic research is leading with nearly 35% market share, owing to extensive research opportunities in infection diagnosis and drug discovery.

Research institutes dominated the end-user segment with a share of around 69.4% in 2020, due to increasing number of molecular biology companies focusing on infection diagnostics after the COVID-19 pandemic.

By region, North America is slated to be the largest market with a value share of 35% by the end of the forecast period (2021 to 2031).

“Advancements in technology and application of digital PCR in drug discovery are anticipated to propel demand for as a measure for disease detection and prevention,” says an analyst of Persistence Market Research.

Market Competition

Acquisitions, mergers, expansions, and product launches are the key strategies adopted by manufacturers to increase their consumer base across geographies.

On October 28, 2021, Bio-Rad Laboratories projected a growth rise in Q3 revenue after acquisition of dPCR maker, Dropworks.

On September 20, 2021, Thermofisher launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.

On January 14, 2019, Qiagen NV agreed to acquire certain molecular testing assets from Formulatrix Inc., including the CONSTELLATION® series of instruments.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the digital PCR market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on the product (instruments, consumables, and service), application (clinical diagnostics, basic research, applied research, and forensic testing), and end user (pharmaceutical companies, research institutes, forensic labs and agriculture companies), across seven key regions of the world.

Key geographies evaluated in this report are: North America – U.S, Canada Europe – France, Germany, Italy, Spain, and the UK, Eastern Europe, CIS APAC – China, India, Japan, Australia, Others Latin America – Argentina, Brazil, Others

Access Full Report@ https://www.persistencemarketresearch.com/checkout/20476

Key Questions Answered in This Report.

What will the Market growth rate in Future?

What are the key factors driving the global Market?

Who are the key manufacturers in Market space?

What are the opportunities and threats faced by the vendors in the global industry?

What are sales, revenue, and price analysis by regions of industry?

About Us: Persistence Market Research

Contact Us:

Persistence Market Research           Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 Sales – sales@persistencemarketresearch.com